Billing & Coding Guide for the Intravenous (IV) Formulation of COSENTYX® (secukinumab)

Access the Full Guide Here

We know that navigating insurance and reimbursement can be a challenge. This guide is intended to provide an overview of coding and coverage information related to the IV formulation of COSENTYX® (secukinumab). Healthcare professionals (HCPs) can reference this guide, in addition to other resources, to determine for themselves the appropriate claims to file for the IV formulation of COSENTYX and related services. Novartis does not guarantee payment or coverage for any product or service. Information specific to coding and billing is subject to change without notice and should be verified by the provider for each patient prior to treatment. It is always the provider’s responsibility to determine the appropriate healthcare setting, and to submit true and correct claims for the products and services rendered. Providers should contact third-party health plans for specific information on their coding, coverage, and payment policies, and fee schedules.